Press "Enter" to skip to content

New patent for Benuvia drug SYNDROS

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SYNDROS
Annual Drug Patent Expirations for SYNDROS

Syndros is a drug marketed by Benuvia and is included in one NDA. There are three patents protecting this drug and two Paragraph IV challenges.

Drug patent litigation for SYNDROS.

This drug has four patent family members in four countries.

The generic ingredient in SYNDROS is dronabinol. Additional details are available on the dronabinol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions